Author(s):
Akash Shelke, Someshwar Mankar, Mahesh Kolhe
Email(s):
Shelkeakash2014@gmail.com
DOI:
10.52711/2349-2988.2021.00015 
Address:
Akash Shelke*, Someshwar Mankar, Mahesh Kolhe
Department of Quality Assurance Techniques, Prvara Rural College of Pharmacy, Pravaranagar, Tal- Rahata, Dist- Ahmednagar 413736, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 2,
Year - 2021
ABSTRACT:
Objective of the present work is to develop and validate a simple, cost effective, sensitive and fast HPLC method for the analysis of Secnidazole. A Merck-Hitachi HPLC system with Peerless Basic C18 (50mm x 4.6mm x 3µm) column is employed for the analysis using buffer: methanol (80:20, v/v) as mobile phase. Signal from Secnidazole is detected at 310nm by UV Spectrophotometer. The proposed method is fully validated and found to be linear over a workable drug concentration, accurate, precise and robust. This fast and inexpensive method is suitable for research laboratories as well as for quality control analysis in pharmaceutical industries.
Cite this article:
Akash Shelke, Someshwar Mankar, Mahesh Kolhe. Development and Validation of RP-HPLC Method for estimation of Secnidazole in API and Pharmaceutical Dosage Form. Research Journal of Science and Technology. 2021; 13(2):100-4. doi: 10.52711/2349-2988.2021.00015
Cite(Electronic):
Akash Shelke, Someshwar Mankar, Mahesh Kolhe. Development and Validation of RP-HPLC Method for estimation of Secnidazole in API and Pharmaceutical Dosage Form. Research Journal of Science and Technology. 2021; 13(2):100-4. doi: 10.52711/2349-2988.2021.00015 Available on: https://rjstonline.com/AbstractView.aspx?PID=2021-13-2-6
REFERENCE:
1. Paul Nyirjesy and Jane R Schwebke; Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment; Future microbiology, Vol. 13, No. 5.
2. Mohamed A. Abd El Aziz, Foruzan Sharifipour, Parvin Abedi, Shayesteh Jahanfar and Helen Marie Judge; Secnidazole for treatment of bacterial vaginosis: a systematic review, BMC Women’s Health volume 19, Article number: 121 (2019)
3. Vishal Singh, Kritarth Nama; Secnidazole Oral Granules: A Novel Drug Formulation and an Effective Alternative in Treatment of Bacterial Vaginosis; International Journal of Innovative Research and Growth 2018;3(4).
4. National library of medicine, pubchem, secnidazol.
5. Edwards DI.; Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action; J Antimicrob Chemo-ther 1993; 31: 9-2.
6. Van Reken DE, Pearson RD. Antiparasitic Agents. In: Mandell GL, Douglas Jr RG, Bennett JE, editors; Principles and practice of infectious diseases; 3rd ed. New York: Churchill Livingstone, 1990: 398-427.
7. Jane c. Gillis and Lynda R. Wiseman; Secnidazole A Review of its Antimicrobial Activity, Pharmacokinetic Properties and Therapeutic Use in the Management of Protozoal Infections and Bacterial Vaginosis Drugs; Drug evaluation, 1996; 51 (4): 621-638
8. Rajan V. Rele, Sandip P. Patil; Development of Analytical method by RP-HPLC Technique for determination of Secnidazole in API and Pharmaceutical Dosage Form; Research J. Pharm. and Tech. 2019;12(10): -4799.
9. Tanzina Sharmin, Mariyam Akter and Mohammad Salim Hossain; Analytical method development and validation of Secnidazole in the tablet dosage form by RP-HPLC method; International Current Pharmaceutical Journal, March 2016, 5(4): 41-44.